Amgen Inc. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amgen Inc. with three other
pharmaceutical manufacturers in North America:
Eli Lilly and Company
sales of $21.22 billion
of which 38%
Teva Pharmaceutical Industries Limited
of which 55%
was Generic Madicines), and
of which 100%
Amgen Inc. reported sales of $22.99 billion
December of 2016.
increase of 6.1%
versus 2015, when the company's sales were $21.66 billion.
Sales at Amgen Inc. have increased during each of the previous five years
(and since 2011, sales have increased a total of 48%).